Oral Wafer Technology: Revolutionizing Drug Delivery for Enhanced Patient Compliance and Bioavailability of Specific Low Dose Drug Categories

Abstract

Oral wafer technology has emerged as a significant innovation in pharmaceutical drug delivery, offering enhanced therapeutic efficacy, patient compliance, and ease of administration compared to conventional dosage forms. These thin, rapidly dissolving films eliminate the need for water, making them particularly advantageous for pediatric, geriatric, and dysphagic populations. The formulation of oral wafers is primarily based on hydrophilic polymers, facilitating rapid disintegration, improved bioavailability, and controlled drug release. Recent advancements have expanded their applications beyond fast-dissolving oral wafers to include mucoadhesive and melt-away formulations, enabling prolonged drug release and targeted therapeutic effects. The integration of nanotechnology, including drug-loaded nanoparticles and liposomal systems, has significantly enhanced solubility, precision targeting, and bioavailability. Additionally, state-of-the-art manufacturing techniques such as solvent casting, hot-melt extrusion, electrospinning, and 3D printing have improved scalability, formulation consistency, and mechanical stability. These wafers are now being explored for a wide range of therapeutic applications, including pain management, neurological disorders, cardiovascular treatments, and pediatric drug delivery, demonstrating their versatility and clinical relevance. This review aims to provide a comprehensive analysis of the advancements in oral wafer technology, with a focus on formulation strategies, material selection, and their impact on drug release kinetics. Furthermore, it highlights recent applications, in vivo study outcomes, and emerging trends in personalized medicine to illustrate their clinical significance. Despite these advancements, challenges related to stability, moisture sensitivity, and dose uniformity persist. Ongoing research focuses on optimizing biodegradable polymers, smart drug delivery systems, and AI-driven formulation strategies to enhance therapeutic precision and patient adherence. The integration of personalized medicine through 3D-printed wafers is anticipated to revolutionize drug administration by enabling tailored treatments. By addressing these limitations and leveraging emerging technologies, oral wafer technology is set to transform pharmaceutical therapeutics, establishing itself as a highly promising alternative to traditional oral drug delivery systems. Graphical Abstract